Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beiersdorf AG

www.beiersdorf.com

Latest From Beiersdorf AG

CBD Beauty Claims Based On Third-Party Studies Could Be Litigation Targets – Venable Attorney

There’s a growing body of scientific evidence linking cannabidiol to benefits of interest to beauty industry players, but if a company’s CBD ingredient differs from the substance studied, that could be grounds for a false-advertising complaint. Venable partner Todd Halpern discusses.

United States Beauty

AESGP Annual Meeting, Day 2: Grappling With Environmental Concerns, 'Nudging' Towards Self-Care Adoption, And Future Trends

A wide range of speakers, such as from GSK and RB, as well as the European Commission, OECD and Deloitte, debated at the AESGP's Annual Meeting in Geneva global self-care policy, how environmental concerns impact industry, ways to ‘nudge’ consumers towards OTCs, and future trends in the market.

OTC Drugs Policy

California Federal Court: Products That Firm Skin Via Moisturization Could Be Unapproved Drugs

Plaintiff Ashley Franz’s claim that Beiersdorf’s Nivea Skin Firming Hydration Body Lotion is an unlawfully marketed drug clears the “relatively low bar of plausibility,” a California federal court determined May 21, denying the firm’s latest bid for dismissal. However, the court intriguingly suggests a motion for summary judgment could be “appropriate” before addressing class certification.

Beauty Legal Issues

Beiersdorf To Enter US Sun Care With Curiously Timed Coppertone Acquisition

The Germany-based skin-care specialist will pay Bayer $550m for the iconic brand and gain entry to the US sunscreen market. The US represents the world’s biggest opportunity for sun care, but it’s also rife with uncertainty following FDA’s recent call for data to support key active ingredients’ continued GRASE status.

Health M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Beiersdorf AG
  • Senior Management
  • Thomas Quaas, CEO
    Iain Holding, Corp. VP, Global Sales Strategy
  • Contact Info
  • Beiersdorf AG
    Phone: (49) 40 4909 0
    Unnastrasse 48
    Hamburg, 20245
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register